Yale School of Medicine IBD Program — New Haven, Connecticut

Yale School of Medicine IBD Program is a clinical research site located in New Haven, Connecticut, United States 06520.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Yale School of Medicine IBD Program has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Crohn's Disease, Ulcerative Colitis, Inflammatory Bowel Diseases.

Sponsors: Dartmouth-Hitchcock Medical Center.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale School of Medicine IBD Program?

Yale School of Medicine IBD Program has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale School of Medicine IBD Program conducted?

Yale School of Medicine IBD Program has 1 clinical trials on record, with 1 currently active. Their work covers Crohn's Disease, Ulcerative Colitis, Inflammatory Bowel Diseases.

Is Yale School of Medicine IBD Program accredited by Crixeo Health?

Yale School of Medicine IBD Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale School of Medicine IBD Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.